Escalon Medical Corporation (ESMC)
Stock Price:
$0.1347 USD
0.0000 (0.00%)
Updated November 27, 10:32 AM EST - Market closed
Key Info
| Market Cap |
998,845 |
| Revenue (ttm) |
9.53M |
| Net Income (ttm) |
-1.52M |
| Shares Out |
7.42M |
| EPS (ttm) |
-0.21 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$0.1347 |
| Previous Close |
$0.1347 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
0.1347 |
| Day's Range |
0.1347 - 0.1347 |
| Day's Volume |
2,500 |
| 52-Week Range |
0.08 - 0.2 |
More Stats
| Market Cap |
998,845 |
| Enterprise Value |
1.35M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
7.42M |
| Float |
7.27M |
| EPS (basic) |
-0.20 |
| EPS (diluted) |
-0.21 |
| FCF / Share |
0.04 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
30.60% |
| Payout Ratio |
n/a |
| Shares Short |
2,007 |
| Short Ratio |
0.31 |
| Short % of Float |
0.03% |
| Beta |
-0.87 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
3.27 |
| PS Ratio |
0.10 |
| PB Ratio |
1.11 |
| Revenue |
9.53M |
| Operating Income |
-1.46M |
| Net Income |
-1.52M |
| Free Cash Flow |
305,667 |
| Net Cash |
-353,480 |
| Net Cash / Share |
-0.05 |
| Gross Margin |
44.11% |
| Operating Margin |
-15.30% |
| Profit Margin |
-16.00% |
| FCF Margin |
3.21% |
| ROA |
-9.02% |
| ROE |
-71.64% |
| ROIC |
-43.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
7.00
Current: $0.1347
High
7.00
Target: 7.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | 9.40 | 9.63 | 11.40 | 11.23 | 11.58 | 13.14 | 12.35 | 11.50 | 11.46 | 25.58 |
| Revenue Growth | -2.35% | -15.57% | 1.49% | -2.95% | -11.87% | 6.33% | 7.45% | 0.31% | -55.19% | - |
| Gross Profit | 4.20 | 4.63 | 5.10 | 5.15 | 5.38 | 6.13 | 6.06 | 5.59 | 5.70 | 8.33 |
| Operating Income | -1.40 | -0.25 | 0.20 | -0.63 | -1.14 | -1.05 | -0.36 | -1.23 | -1.32 | -4.86 |
| Net Income | -0.65 | -0.25 | 0.58 | -0.73 | -1.15 | -0.54 | -0.38 | 2.62 | -5.94 | -5.76 |
| Shares Outstanding | 7.42 | 7.42 | 7.55 | 7.55 | 7.54 | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 |
| Earnings Per Share | -0.09 | -0.04 | 0.06 | -0.10 | -0.15 | -0.07 | -0.05 | 0.35 | -0.79 | -0.77 |
| Operating Cash Flow | -0.17 | -0.47 | 0.11 | -0.51 | -1.02 | -0.46 | -0.62 | -1.93 | -0.70 | -0.51 |
| Capital Expenditures | -0.06 | -0.02 | -0.04 | -0.01 | -0.23 | -0.04 | -0.02 | -0.01 | -0.08 | -0.25 |
| Free Cash Flow | -0.23 | -0.49 | 0.06 | -0.51 | -1.25 | -0.49 | -0.65 | -1.95 | -0.78 | -0.77 |
| Cash & Equivalents | 1.08 | 0.66 | 1.12 | 0.54 | 0.54 | 1.52 | 2.01 | 2.65 | 0.89 | 1.51 |
| Total Debt | 2.04 | 0.22 | 0.19 | 0.80 | 0.28 | - | - | - | 4.45 | 4.78 |
| Net Cash / Debt | -0.96 | 0.44 | 0.94 | -0.25 | 0.26 | 1.52 | 2.01 | 2.65 | -3.56 | -3.27 |
| Assets | 5.72 | 5.13 | 5.43 | 4.98 | 5.53 | 6.55 | 7.66 | 7.27 | 9.75 | 17.28 |
| Liabilities | 4.21 | 2.97 | 3.01 | 3.80 | 3.62 | 3.56 | 4.19 | 3.44 | 9.11 | 11.09 |
| Book Value | 1.51 | 2.16 | 2.41 | 1.18 | 1.91 | 2.99 | 3.46 | 3.83 | 0.64 | 6.19 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Escalon Medical Corporation |
| Country |
United States |
| Employees |
38 |
| CEO |
Richard J. DePiano |
Stock Information
| Ticker Symbol |
ESMC |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
OTCMKTS: ESMC |
| IPO Date |
September 11, 1992 |
Description
Escalon Medical develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.